An audience with Tatiana Prowell. Interviewed by Asher Mullard.
作者信息
Prowell Tatiana
出版信息
Nat Rev Drug Discov. 2014 Jun;13(6):410-1. doi: 10.1038/nrd4335.
DOI:10.1038/nrd4335
PMID:24875091
Abstract
摘要
相似文献
1
An audience with Tatiana Prowell. Interviewed by Asher Mullard.对塔蒂亚娜·普罗韦尔的访谈。采访者：亚瑟·穆拉德。
Nat Rev Drug Discov. 2014 Jun;13(6):410-1. doi: 10.1038/nrd4335.
2
Cancer drugs. Weighing the risks and benefits.抗癌药物。权衡风险与益处。
FDA Consum. 2007 Jan-Feb;41(1):10-9.
3
Neoadjuvant trials could speed up drug approvals.新辅助试验可以加快药物审批。
J Natl Cancer Inst. 2014 Mar;106(3):dju072. doi: 10.1093/jnci/dju072. Epub 2014 Mar 7.
4
"Right to Try" Laws: The Gap between Experts and Advocates.“尝试权”法律：专家与倡导者之间的差距
Hastings Cent Rep. 2015 May-Jun;45(3):9-10. doi: 10.1002/hast.442.
5
Can single-patient investigational new drug studies hurry slow trains to the fast track?单患者研究性新药研究能否让慢车加速驶入快车道？
Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4.
6
7
Experimental drugs on trial.正在试验的实验性药物。
Sci Am. 2007 Oct;297(4):92-9. doi: 10.1038/scientificamerican1007-92.
8
Accelerated approval regulations may need overhaul, panel suggests.专家小组建议，加速批准法规可能需要全面修订。
J Natl Cancer Inst. 2005 Dec 21;97(24):1802-4. doi: 10.1093/jnci/dji456.
9
Regulatory watch: Why do oncology drugs fail to gain US regulatory approval?监管观察：肿瘤药物为何未能获得美国监管批准？
Nat Rev Drug Discov. 2015 Jul;14(7):450-1. doi: 10.1038/nrd4651. Epub 2015 May 22.
10
Demand grows for early access to promising cancer drugs.
J Natl Cancer Inst. 2002 Nov 20;94(22):1668-70. doi: 10.1093/jnci/94.22.1668.
引用本文的文献
1
Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.用于优化抗血管生成疗法的系统药理学方法：挑战与机遇
Front Pharmacol. 2015 Feb 20;6:33. doi: 10.3389/fphar.2015.00033. eCollection 2015.
Zotero 插件